Additional file 2: of Use of targeted next generation sequencing to characterize tumor mutational burden and efficacy of immune checkpoint inhibition in small cell lung cancer
- Biagio Ricciuti (6409355)
- Sasha Kravets (5545475)
- Suzanne Dahlberg (6525611)
- Renato Umeton (413065)
- Adem Albayrak (6525617)
- Safiya Subegdjo (6525620)
- Bruce Johnson (772564)
- Mizuki Nishino (6525623)
- Lynette Sholl (3564347)
- Mark Awad (6525626)
Publication date
March 2019
DOIAbstract
Figure S2. Box plot showing the distribution of TMB between the entire cohort of patients with SCLC and the cohort of patients with SCLC treated with immune checkpoint inhibitors. Box plots represent medians, interquartile ranges, and vertical lines extend to the highest and the lowest TMB values. TMB of individual patients are represented with dots. (DOCX 81 kb
Add to ORKG